Chulalongkorn University Executives Visit Amgen Inc. to Discuss Future Academic Collaborations
A delegation from Chulalongkorn University, including the Vice President and various faculty executives, conducted a visit to Amgen Inc. on June 4, 2025. Amgen Inc. is a biotechnology company headquartered in the United States, known for its development of biologic medicines and biosimilars aimed at treating conditions such as cancer, kidney disease, and autoimmune disorders.
Insights from Amgen
During the visit, Amgen representatives provided insights into the company’s research and development strategies, biomanufacturing processes, and global collaborative initiatives. The Chulalongkorn University delegation also had the opportunity to tour Amgen’s manufacturing facilities.
Exploring Collaborations
The discussions between the two parties focused on exploring potential academic and industrial collaborations, highlighting an interest in fostering partnerships in the biotechnology sector.
(Source: Chulalongkorn University)
